Soligenix, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Princeton, NJ
SNGX chart
What traders are saying about $SNGX
Latest postsSoligenix, Inc. news
- Soligenix, Inc. Estimates – NASDAQ:SNGX
TradingView ·
- Radiotherapy-Induced Oral Mucositis Market Set for Strong Growth Through 2036, Driven by Emerging Therapies and Rising Cancer Burden | DelveInsight
Yahoo Finance ·
- SNGX: Applying for Vaccine Development Funding for Ebola Vaccine
Yahoo Finance ·
- Soligenix culls topical lymphoma asset after Phase III miss
clinicaltrialsarena.com ·
- Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
Yahoo Finance ·
- Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
Yahoo Finance ·
- SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month – Ebola Vaccine Optimism Fuels Retail Frenzy
stocktwits.com ·
- Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
Yahoo Finance ·
- SNGX: Continuing to Analyze FLASH2 Data
Yahoo Finance ·
- Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
Yahoo Finance ·
- SNGX: FLASH2 Trial Recommended to Stop for Futility
Yahoo Finance ·
- SNGX Phase 3 Trial Halted on HyBryte
investorshub.advfn.com ·
Soligenix, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $119,371 | $839,359 | $948,911 |
| Net income | -$11.1M | -$8.3M | -$6.1M | -$13.8M |
| Diluted EPS | $-2.14 | $-4.98 | $-12.66 | $-4.81 |
| Total assets (year end) | $9.2M | $9.0M | $9.8M | $14.3M |
| Cash and equivalents (year end) | – | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Soligenix, Inc.
- Ticker
- SNGX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 812796
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP
Frequently asked questions
What exchange is Soligenix, Inc. listed on?
Soligenix, Inc. trades on the Nasdaq under the ticker symbol SNGX.
What industry is Soligenix, Inc. in?
Soligenix, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Soligenix, Inc. headquartered?
Soligenix, Inc.'s business address on file with the SEC is in Princeton, NJ.
When does Soligenix, Inc.'s fiscal year end?
Soligenix, Inc.'s fiscal year ends on December 31.
How much revenue did Soligenix, Inc. report?
Soligenix, Inc. reported $119,371 in revenue for calendar year 2024, according to its SEC filings.